Agrylin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Anagrelide Hydrochloride.
| Product ID | 54092-063_2e8a557f-0338-47ff-9ba8-ff4bbf193d1b | 
| NDC | 54092-063 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Agrylin | 
| Generic Name | Anagrelide Hydrochloride | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 1997-03-14 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020333 | 
| Labeler Name | Takeda Pharmaceuticals America, Inc. | 
| Substance Name | ANAGRELIDE HYDROCHLORIDE | 
| Active Ingredient Strength | 1 mg/1 | 
| Pharm Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 1997-03-14 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020333 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1997-03-14 | 
| Ingredient | Strength | 
|---|---|
| ANAGRELIDE HYDROCHLORIDE | .5 mg/1 | 
| SPL SET ID: | cb960074-99c1-4a73-941f-f0644a7ec219 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 54092-063 | Agrylin | anagrelide hydrochloride | 
| 0172-5240 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | 
| 0172-5241 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | 
| 68151-2959 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() AGRYLIN  78609806  3119751 Live/Registered  | 
        Shire LLC  2005-04-15  | 
![]() AGRYLIN  75195604  2160991 Dead/Cancelled  | 
        SHIRE LLC  1996-11-12  |